# TAZAROTENE
> **ANDA215393** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2025-07-29
## Drug
- **FDA Application Number:** ANDA215393
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TAZAROTENE
- **Generic name:** Tazarotene
- **Active ingredients:** TAZAROTENE
- **Dosage form:** LOTION
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS ISRAEL
- **First approval:** 2025-07-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215393)
---
*AI Analytics · CC0 1.0*